Recent Finacing
Recent Raise
Gemphire Therapeutics develops gemcabene, an oral lipid‑lowering small molecule with statin‑like pleiotropic effects as adjunctive therapy to lower LDL‑C, hsCRP, and triglycerides, advancing into Phase 2b and manufacturing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor